Literature DB >> 33727525

4SCAR2.0: a multi-CAR-T therapy regimen for the treatment of relapsed/refractory B cell lymphomas.

Cheng Jiao1,2, Eugene Zvonkov3, Xun Lai4, Rui Zhang1, Yuchen Liu1, Yue Qin5, Valery Savchenko3, Nelly Gabeeva3, Tsai-Hua Chung1,5, Liyuan Sheng2,6, Lung-Ji Chang7,8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33727525      PMCID： PMC7966809          DOI： 10.1038/s41408-021-00455-x

Source DB:  PubMed          Journal:  Blood Cancer J        ISSN： 2044-5385            Impact factor:   11.037


× No keyword cloud information.
  10 in total

Review 1.  Chimeric antigen receptor T cell therapy: 25years in the making.

Authors:  Saar Gill; Marcela V Maus; David L Porter
Journal:  Blood Rev       Date:  2015-11-06       Impact factor: 8.250

Review 2.  Tumor Antigen Escape from CAR T-cell Therapy.

Authors:  Robbie G Majzner; Crystal L Mackall
Journal:  Cancer Discov       Date:  2018-08-22       Impact factor: 39.397

Review 3.  How I treat primary mediastinal B-cell lymphoma.

Authors:  Lisa Giulino-Roth
Journal:  Blood       Date:  2018-07-05       Impact factor: 22.113

Review 4.  Development of adaptive immune effector therapies in solid tumors.

Authors:  P Comoli; C Chabannon; U Koehl; F Lanza; A Urbano-Ispizua; M Hudecek; A Ruggeri; S Secondino; C Bonini; P Pedrazzoli
Journal:  Ann Oncol       Date:  2019-11-01       Impact factor: 32.976

Review 5.  Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach?

Authors:  Kieron Dunleavy; Wyndham H Wilson
Journal:  Blood       Date:  2014-12-11       Impact factor: 22.113

Review 6.  Enhancing CAR T cell efficacy: the next step toward a clinical revolution?

Authors:  Manjusha Namuduri; Renier J Brentjens
Journal:  Expert Rev Hematol       Date:  2020-04-27       Impact factor: 2.929

7.  Overcoming Antigen Escape with CAR T-cell Therapy.

Authors:  Hollie J Jackson; Renier J Brentjens
Journal:  Cancer Discov       Date:  2015-12       Impact factor: 39.397

Review 8.  Biology and therapy of primary mediastinal B-cell lymphoma: current status and future directions.

Authors:  Charlotte Lees; Colm Keane; Maher K Gandhi; Jay Gunawardana
Journal:  Br J Haematol       Date:  2019-02-10       Impact factor: 6.998

Review 9.  CAR T Cells for Solid Tumors: New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment.

Authors:  Marina Martinez; Edmund Kyung Moon
Journal:  Front Immunol       Date:  2019-02-05       Impact factor: 7.561

Review 10.  Current Progress in CAR-T Cell Therapy for Solid Tumors.

Authors:  Shuo Ma; Xinchun Li; Xinyue Wang; Liang Cheng; Zhong Li; Changzheng Zhang; Zhenlong Ye; Qijun Qian
Journal:  Int J Biol Sci       Date:  2019-09-07       Impact factor: 6.580
  10 in total
  1 in total

Review 1.  The Implementation of TNFRSF Co-Stimulatory Domains in CAR-T Cells for Optimal Functional Activity.

Authors:  Yuan He; Martijn Vlaming; Tom van Meerten; Edwin Bremer
Journal:  Cancers (Basel)       Date:  2022-01-08       Impact factor: 6.639
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.